期刊文献+

帕金森病基因α-Synuclein过表达对秀丽隐杆线虫毒性作用的研究 被引量:4

Toxic effect of Parkinson's disease gene α-Synuclein on caenorhabditis elegans
下载PDF
导出
摘要 目的:利用载体pPD95.86建立携带帕金森病基因α-Synuclein(α-SYN)的秀丽隐杆线虫(秀丽线虫)模型,探讨α-SYN过表达对秀丽线虫的毒性作用。方法:构建同时表达α-SYN和绿色荧光蛋白(GFP)的重组质粒pPD95.86::α-SYN,采用野生型N2秀丽线虫,通过显微注射和基因整合筛选获得pPD95.86转基因线虫和pPD95.86::α-SYN转基因线虫。同步化野生型N2秀丽线虫和两种转基因线虫,以pPD95.86::α-SYN转基因线虫为实验组,以pPD95.86转基因线虫为条件对照组,以N2野生型线虫为空白对照组,观察3组线虫的寿命、运动能力和热休克条件下的存活情况。结果:与两对照组比较,pPD95.86::α-SYN转基因线虫的寿命明显缩短,运动能力显著下降,热休克条件下其存活能力减弱(P均<0.01)。结论:帕金森病基因α-SYN的过表达对秀丽线虫具有明显的毒性作用,并且该毒性在热休克条件下加重。 Objective: To establish a transgenic caenorhabditis elegans (C. elegans) model of human ct-synu- clein with the vector pPD95.86 and explore the toxic effects of α-synuclein overexpression on the life-span of elegans. Methods: Human α-synuclein and the green fluorescent protein (GFP) were fused and cloned into the vector pPD95.86. Transgenic C. elegans with pPD95.86 and pPD95.86: : α-SYN were produced by microinjecting the recombinant plasmid into wild-type worms and gene integration. Transgenic C. elegans with pPD95.86 : α-SYN were divided into experimental group, transgenic C. elegans with pPD95.86 into control conditions, and N2 wild-type C. elegans into blank control group The effects of α-synuclein expression on the life-span were studied. Results: Compared with two control group, transgenic C. elegans with pPD95.86: α-SYN had significant shorter life span and their motor function was impaired ( all P 〈 0.01 ). Exposure to the heat stress significantly compromised the viability of transgenic C. elegans expressing human α-synuclein (P 〈0. 01 ). Conclusion: Human α-synuclein expressing in muscle cells of C. elegans decreases the life-span of elegans
出处 《新医学》 2013年第4期273-277,共5页 Journal of New Medicine
基金 国家自然科学基金(30770766) 广东省科技计划项目(2012B031800107)
关键词 Α-突触核蛋白 秀丽线虫 寿命 热休克 α-Synuclein Caenorhabditis elegans Life-span Heat shock
  • 相关文献

参考文献11

  • 1Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-Synuclein causes Parkin- son and Lewy body dementia. Ann Neurol, 2004, 55 : 164-173.
  • 2Spillantini MG, Schmidt ML, Lee VM, et al. Alpha- synuclein in Lewy bodies. Nature, 1997, 388: 839- 840.
  • 3Sternberg PW. Working in the post-genomic C. elegans world. Cell, 2001, 105: 173-176.
  • 4Harrington AJ, Hamamichi S, Caldwell GA, et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev Dyn, 2010, 239: 1282-1295.
  • 5Brenner S. The genetics of Caenorhabditis elegans. Ge- netics, 1974, 77: 71-94.
  • 6Lok JB. Strongyloides stercoralis: a model for transla- tional research on parasitic nematode biology. Worm- Book, 2007, 17. 1-18.
  • 7Suvi V, Vuokko A, Merja J, et al. Increased lifespan in transgenic Caenorhabditis elegans overexpressing human alpha-synuclein. Exp Gerontol, 2006, 41 : 871-876.
  • 8Tsalik EL, Hobert O. Functional mapping of neuronsthat control locomotory behavior in Caenorhabditis ele- gans. J Neurobiol, 2003, 56: 178-197.
  • 9KampkO tter A, Timpel C, Zurawski RF, et al. Increase of stress resistance and lifespan of Caenorhabditis ele- gans by quercetin. Comp Biochem Physiol B Biochem Mol Biol, 2008, 149: 314-323.
  • 10Winslow AR, Chen CW, Corrochano S, et al. Synu- clein impairs macroautophagy: implications for Parkin- son ~ disease. J Cell Biol, 2010, 190: 1023-1037.

同被引文献95

  • 1韩焱,杨慧敏,宋少娟,杨美玲,郭亚平,马恩波.马拉硫磷对秀丽隐杆线虫的急性毒性研究[J].山西大学学报(自然科学版),2012,35(3):563-567. 被引量:4
  • 2Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Tro- janowski JQ, Lee VM. Pathological c:-synuclein? Trans- mission initiates? Parkinson-like neurodegeneration in nontransgenic mice. Science, 2012, 338 (6109): 949-953.
  • 3Yu S, Zuo X, Li Y, Zhang C, Zhou M, Zhang YA, U:da K, Chan P. Inhibition of tyrosine hydroxylase ex- pression in alpha-synuclein-transfected dopaminergic neu- ronalcells. Neurosci Lett, 2004, 367 (1): 34-39.
  • 4Lee D, Paik SR, Choi KY. Beta-synuclein exhibits chap- erone activity more efficiently than alpha-synuelein. FEBS Letters, 2004, 576 (1-2): 256-260.
  • 5Ozansoy M, Basak AN. The central theme of Parkinson's disease: c:-synuclein. Mol Neurobiol, 2013, 47 (2): 460-465.
  • 6Marwarha G, Rhen T, Sehommer T, Ghribi O. The oxys- terol 27-hydroxycholesterol regulates et-synuclein and tyrosine hydroxylase expression levels in human neuro- blastoma cells through modulation of liver X receptors and estrogen receptors-Relevance to Parkinson's disease. J Neurochem, 2011, 119 (5) : 1119-1136.
  • 7Gao N, Li YH, Li X, Yu S, Fu GL, Chen B. Effect of ot-synuclein on the promoter activity of tyrosine hydroxy- lase gene. Neuroscience Bulletin, 2007, 23 ( 1 ) : 53- 57.
  • 8Vigneswara V, Cass S, Wayne D, Bolt EL, Ray DE, Carter WG. Molecular Ageing of Alpha- and Beta-Synu- cleins: Protein Damage and Repair Mechanisms. PloS One, 2013, 8 (4): e61442.
  • 9Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson' s disease [ J ]. Adv Anat Embryol Cell Biol,2009,201 ( 1 ) : 1-119.
  • 10Hasegawa T, Treis A, Patenge N, et al. Parkin protects a- gainst tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways [ J ]. J Neuroehem,2008,105 (5) : 1700-1715.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部